Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape
CNS Drugs · 2025-03 · 39 (3) · 243-262
DOI: 10.1007/s40263-024-01151-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Drugs, online erschienen am 12.01.2025. Verfasst von Preetika Govil und 1 weiteren Autor:innen. Beteiligte Einrichtung: New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Schizophrenic Psychology. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 202 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA.
- New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. Joshua.kantrowitz@nyspi.columbia.edu.
- College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA. Joshua.kantrowitz@nyspi.columbia.edu.
- Nathan Kline Institute, Orangeburg, NY, 10962, USA. Joshua.kantrowitz@nyspi.columbia.edu.
ORCID-Profile: Preetika Govil, Joshua T Kantrowitz
Zitieren
APA
Govil, P., & Kantrowitz, J. T. (2025). Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape. CNS Drugs, 39(3), 243-262. https://doi.org/10.1007/s40263-024-01151-7
Vancouver
Govil P, Kantrowitz JT. Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape. CNS Drugs. 2025;39(3):243-262. doi:10.1007/s40263-024-01151-7
BibTeX
@article{Govil2025,
author = {Govil, Preetika and Kantrowitz, Joshua T},
title = {Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape},
journal = {CNS Drugs},
year = {2025},
volume = {39},
number = {3},
pages = {243--262},
doi = {10.1007/s40263-024-01151-7}
}
EUVIMED